1219
福壽
-0.05 (-0.45%)11.15153成交張數–本益比0.96股價淨值比4.46%殖利率2026-09-16資料日期
綜合損益表公開資訊觀測站申報原值 · 年度(第 4 季累計) · 每一格 = 該期對去年同期的成長率
營業收入202514,382年增 +0.4%
毛利率20258.5%最新一期
營業利益率20250.0%最新一期
每股盈餘20250.45年增 -15.1%
| 會計項目 | 走勢 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 銷貨收入 | – | -1.3% | +8.2% | +4.7% | – | – | +15.0% | -4.0% | -12.2% | +0.4% | |
| 銷貨收入淨額 | – | -1.3% | +8.2% | +4.7% | +0.5% | +19.9% | +15.0% | -4.0% | -12.2% | +0.4% | |
| 營業收入合計 | – | -1.3% | +8.2% | +4.7% | +0.5% | +19.9% | +15.0% | -4.0% | -12.2% | +0.4% | |
| 營業成本合計 | – | -0.6% | +9.8% | +3.3% | -2.6% | +22.2% | +15.9% | -4.6% | -12.3% | +1.1% | |
| 生物資產當期公允價值減出售成本之變動利益(損失) | – | – | – | – | – | -152.4% | – | – | +305.1% | -170.4% | |
| 營業毛利（毛損） | – | -8.6% | -11.9% | +26.1% | +36.4% | +0.2% | +6.9% | +2.6% | -9.6% | -9.1% | |
| 未實現銷貨（損）益 | – | – | – | – | – | – | – | +57.1% | -64.0% | -8.8% | |
| 已實現銷貨（損）益 | – | – | – | – | – | – | – | – | -8.3% | -64.0% | |
| 營業毛利（毛損）淨額 | – | -8.6% | -11.9% | +26.1% | +36.4% | +0.2% | +6.9% | +2.7% | -9.6% | -9.1% | |
| 推銷費用 | – | -1.4% | +4.8% | +8.2% | +1.9% | +10.1% | +6.7% | -3.0% | +9.2% | -1.4% | |
| 管理費用 | – | -4.7% | -10.5% | +9.9% | +17.5% | -3.8% | +1.3% | +6.8% | +10.2% | -2.2% | |
| 研究發展費用 | – | +5.2% | +14.7% | -5.1% | -9.3% | +0.4% | +57.1% | -15.6% | +3.0% | -4.7% | |
| 預期信用減損損失（利益） | – | – | – | – | +166.9% | -220.8% | – | +118.5% | -114.8% | – | |
| 營業費用合計 | – | -2.2% | -1.4% | +10.3% | +6.7% | +3.1% | +8.1% | -0.7% | +8.9% | -1.2% | |
| 營業利益（損失） | – | -85.5% | -854.1% | – | +891.3% | -8.7% | +2.4% | +15.2% | -68.6% | -97.1% | |
| 利息收入 | – | – | – | – | – | +222.5% | +15.1% | +82.7% | +10.1% | +3.4% | |
| 其他收入 | – | -16.2% | -10.5% | +40.5% | +94.5% | -33.9% | -8.9% | +8.7% | +6.9% | +15.9% | |
| 其他利益及損失淨額 | – | +520.8% | -110.1% | – | +104.8% | -99.8% | – | -50.7% | -32.3% | -228.1% | |
| 財務成本淨額 | – | +26.3% | +8.4% | +19.1% | -28.9% | -12.4% | +53.4% | +42.2% | +7.3% | -0.3% | |
| 採用權益法認列之關聯企業及合資損益之份額淨額 | – | +21.4% | +15.3% | +2.8% | +39.4% | +4.3% | +27.0% | -4.6% | +0.9% | +9.6% | |
| 營業外收入及支出合計 | – | +146.9% | -103.0% | – | +142.9% | -85.2% | +29.7% | -50.1% | -18.9% | -21.6% | |
| 稅前淨利（淨損） | – | -39.5% | -247.9% | – | +285.7% | -47.7% | +6.3% | +3.7% | -64.4% | -82.5% | |
| 所得稅費用（利益）合計 | – | -94.9% | +520.7% | +192.7% | +226.6% | -34.5% | -2.5% | -15.9% | -46.9% | -21.3% | |
| 繼續營業單位本期淨利（淨損） | – | -4.6% | -273.9% | – | +299.8% | -50.2% | +8.6% | +8.3% | -67.6% | -100.5% | |
| 本期淨利（淨損） | – | -4.6% | -273.9% | – | +299.8% | -50.2% | +8.6% | +8.3% | -67.6% | -100.5% | |
| 確定福利計畫之再衡量數 | – | – | -106.7% | – | -157.9% | – | – | -106.4% | – | -132.7% | |
| 與不重分類之項目相關之所得稅 | – | – | -107.9% | – | -158.0% | – | – | -106.4% | – | -132.8% | |
| 不重分類至損益之項目： | – | – | – | – | -19.1% | -270.2% | – | -94.5% | – | -132.7% | |
| 國外營運機構財務報表換算之兌換差額 | – | – | – | – | – | -159.2% | – | -218.8% | – | -89.8% | |
| 與可能重分類之項目相關之所得稅 | – | – | – | – | – | -159.2% | – | -218.9% | – | -89.7% | |
| 後續可能重分類至損益之項目： | – | – | – | – | – | -159.2% | – | -218.8% | – | -89.8% | |
| 其他綜合損益（淨額） | – | – | -162.4% | – | – | -193.0% | – | -156.3% | – | -100.4% | |
| 本期綜合損益總額 | – | +79.3% | -267.3% | – | +311.6% | -50.8% | +11.1% | +5.8% | -65.5% | -100.5% | |
| 母公司業主（淨利∕損） | – | -9.8% | -108.0% | – | +202.9% | -47.5% | -0.3% | -2.9% | -42.0% | -14.5% | |
| 非控制權益（淨利∕損） | – | – | – | – | – | – | – | – | -506.4% | – | |
| 母公司業主（綜合損益） | – | +9.7% | -109.2% | – | +208.1% | -48.0% | +1.7% | -4.8% | -39.9% | -16.9% | |
| 非控制權益（綜合損益） | – | – | – | – | – | – | – | – | -512.6% | – | |
| 基本每股盈餘 | – | -10.2% | -106.8% | – | +203.2% | -47.6% | 0.0% | -6.0% | -43.6% | -15.1% | |
| 採用權益法認列之關聯企業及合資之其他綜合損益之份額-不重分類至損益之項目 | – | – | – | – | – | -138.8% | – | -50.7% | -100.0% | – | |
| 銷貨成本 | – | – | – | +3.3% | – | – | – | – | – | – |
金額為公司申報原值除以一千(百萬元,四捨五入),每股金額為元。年度為第 4 季的年初至今累計數。走勢條是歷史各期的相對大小,藍為正、綠為負。年增以去年同期為基期,基期非正數或變動超過十倍時不列。 權益變動表在申報資料分頁。